Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06274723 · ClinicalTrials.gov registry record · NA
Responses to E-cigarette Message Source and Presentation
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 848
- Enrollment target
NCT06274723: Completed NA study, sponsored by University of Massachusetts, Worcester.
NCT06274723 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 848 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06274723, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 848 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to use crowdsourcing to test the effects of a message source (expert and peer) and message presentation types (one-sided and two-sided) to identify the optimal message type for young adults who vape and do not vape.
Primary Outcome
Participants' self-reported message acceptance were measured by using a five-point Likert scale using five items assessing whether participants thought the message was worth remembering, grabbed their attention, powerful, convincing, and meaningful on a scale from 1 (Strongly disagree) to 5 (Strongly agree). Items were summed and averaged to create a single composite score, and this was done for each arm for each vaping status. Higher scores indicate more more message acceptance, therefore bette
Interventions
- OTHER Expert, one-sided
- OTHER Expert, two-sided
- OTHER Peer, one-sided
- OTHER Peer, two-sided
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 848 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2024-12-17 |
| Phase | NA |
What the finished NCT06274723 record still lists
NCT06274723 is an interventional study that assigns participants to a tested intervention. The registered 848 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 4 interventions - of which Expert, one-sided is the first listed.
NCT06274723 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06274723 about?
NCT06274723 is a clinical study titled "Responses to E-cigarette Message Source and Presentation". The goal of this clinical trial is to use crowdsourcing to test the effects of a message source (expert and peer) and message presentation types (one-sided and two-sided) to identify the optimal message type for young adults who vape and do not vape.
What is the current status of trial NCT06274723?
This trial is currently completed. It is a NA study. The enrollment target is 848 participants. The study started on 2024-11-05. Estimated completion is 2024-12-17.
What interventions are being tested in trial NCT06274723?
The interventions under investigation include: Expert, one-sided (OTHER), Expert, two-sided (OTHER), Peer, one-sided (OTHER), Peer, two-sided (OTHER).
Who is sponsoring clinical trial NCT06274723?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06274723's enrollment target sits among peer trials
848 132nd of 2000 higher than 1,869 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07142408 · 848 participants · Phase 3
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05846841 · 850 participants · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
- NCT05987059 · 850 participants · Phase 2
Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI